Open Trial Databases Not Widely Popular – Yet – Duke Researcher Finds
For three major databases allowing researcher access to clinical trial data, few requests were to validate results.
You may also be interested in...
Device companies are not stepping up as much as they should be to make their raw trial data available for analysis by independent researchers, cardiologists said at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
GlaxoSmithKline pleads guilty to promoting Paxil and Wellbutrin off-label and failing to report Avandia safety data to FDA; civil portion of settlement resolves off-label and kickback allegations involving nine products. New corporate integrity agreement gives OIG authority to require a recall.
Senate appropriations bill would take back some of increase House offered Center for Drug Evaluation and Research and other FDA programs, setting up negotiations as start of FY2023 nears.